A robot at the operating table
Midwife, a dream job
My 50 years of dialysis
In battle against the coronavirus
An almost irreplaceable organ
Living life to the fullest with dialysis
Growing up with parenteral nutrition
Paul, the four-legged therapist
The History of Dialysis
Serving patients in Swaziland
"I want to help others, so they won’t give up"
From a local pharmacy to a global corporation
Q1/21 Results
Fresenius with good start to 2021 despite ongoing COVID-19 impact
-
Guidance for 2021 confirmed
-
Fresenius Medical Care delivers solid first quarter
-
Fresenius Kabi shows strong performance in Emerging Markets whilst headwinds continue to impact North American business
-
Helios Germany continues to be compensated by government for foregone elective treatments; Helios Spain delivers significant sales and earnings growth given recovery of treatment activity
-
Fresenius Vamed continues to suffer from COVID-19 related project delays; technical high-end service business remains robust
-
Preparation of Group-wide initiatives to improve efficiency and profitability progressing
